Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides

Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides

US Patent 5407823 · Granted Apr 18, 1995

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2022
Therapeutical use of H3-ligands2021
Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical composi2021
Combination of adrenalin with an antidepressant for use in the treatment of shoc2021
Chromone derivative as a dopamine D3 receptor antagonist for its use for the tre2018
Form of administration of enkephalinase inhibitor2016
Derivatives of azaindazole or diazaindazole type for treating pain2016
Piperidinyl monocarboxylic acids as S1P1 receptor agonists2016
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 recep2016